nilotinib 95 MG Oral Tablet [Danziten]
- RxCUI
- 2698574
- RxNorm name
- nilotinib 95 MG Oral Tablet [Danziten]
- Display name
- nilotinib 95 MG Oral Tablet [Danziten]
- Full name
- nilotinib 95 MG Oral Tablet [Danziten]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DANZITEN | NILOTINIB | Azurity Pharmaceuticals, Inc. | d288d165-3505-49bb-9b2e-124490d65f49 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | 2698574 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d288d165-3505-49bb-9b2e-124490d65f49 | nilotinib 95 MG Oral Tablet [Danziten] | SBD | 3 | These highlights do not include all the information needed to use DANZITEN safely and effectively. See full prescribing information for DANZITEN. DANZITEN (nilotinib) tablets, for oral use Initial U.S. Approval: 2007 | 20250728 |
| d288d165-3505-49bb-9b2e-124490d65f49 | Danziten 95 MG (equivalent to nilotinib tartrate 121.95 MG) Oral Tablet | SY | 3 | These highlights do not include all the information needed to use DANZITEN safely and effectively. See full prescribing information for DANZITEN. DANZITEN (nilotinib) tablets, for oral use Initial U.S. Approval: 2007 | 20250728 |
| d288d165-3505-49bb-9b2e-124490d65f49 | Danziten 95 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use DANZITEN safely and effectively. See full prescribing information for DANZITEN. DANZITEN (nilotinib) tablets, for oral use Initial U.S. Approval: 2007 | 20250728 |